← Back to Search

Treatment for Liver Disease

N/A
Waitlist Available
Led By Arun Sanyal, MD
Research Sponsored by Johns Hopkins Bloomberg School of Public Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 1 year
Awards & highlights

Summary

The NAFLD Database 3 will enroll approximately 1500 adult patients and 750 pediatric patients suspected or known to have NAFLD or NASH-related cirrhosis. To elucidate, through the cooperative effort of a multidisciplinary and multicenter group of collaborators, the etiology, natural history, diagnosis, treatment, and prevention of NAFLD, and in particular its more severe form of NASH and its complications.

Eligible Conditions
  • Liver Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in alanine aminotransferase (ALT) levels from baseline to one year.

Find a Location

Who is running the clinical trial?

Children's Hospital Medical Center, CincinnatiOTHER
827 Previous Clinical Trials
6,562,807 Total Patients Enrolled
Baylor College of MedicineOTHER
1,018 Previous Clinical Trials
6,029,789 Total Patients Enrolled
Case Western Reserve UniversityOTHER
304 Previous Clinical Trials
245,411 Total Patients Enrolled
~268 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top